Загрузка...
Saxagliptin: A dipeptidyl peptidase-4 inhibitor in the treatment of type 2 diabetes mellitus
Type 2 diabetes mellitus (T2DM) is a metabolic disorder characterized by insulin deficiency or resistance. Management starts with single oral antidiabetic drug (OAD) but eventually switch over to combination therapy because of progressive β-cell dysfunction. Hypoglycemia, weight gain, and adverse ca...
Сохранить в:
| Главный автор: | |
|---|---|
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Medknow Publications Pvt Ltd
2011
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3198516/ https://ncbi.nlm.nih.gov/pubmed/22025849 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4103/0976-500X.85934 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|